Related Experiment Video
Updated: Apr 30, 2026
23:33
The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
84.2K
Stroke prevention in nonvalvular atrial fibrillation
G W Albers1, J E Atwood, J Hirsh
1Palo Alto Veterans Affairs Medical Center, CA 94304.
Annals of Internal Medicine
|November 1, 1991
Summary
Low-dose warfarin effectively prevents stroke in nonvalvular atrial fibrillation patients with fewer bleeding risks. Aspirin is also a viable option for select patients, offering stroke prevention benefits.
Area of Science:
- Cardiology
- Neurology
- Pharmacology
Background:
- Nonvalvular atrial fibrillation (NVAF) poses a significant stroke risk.
- Optimal stroke prevention strategies for NVAF remain under investigation.
- Warfarin and aspirin are commonly considered for thromboembolic event prophylaxis.
Purpose of the Study:
- To evaluate the efficacy and safety of low-dose warfarin for stroke prevention in NVAF.
- To compare warfarin therapy with other interventions for stroke prophylaxis.
- To assess the role of aspirin in stroke prevention for NVAF patients.
Main Methods:
- Analysis of four large, prospective, randomized trials.
- Inclusion of patients diagnosed with nonvalvular atrial fibrillation.
- Assessment of stroke incidence and bleeding complications.
Main Results:
- Warfarin therapy significantly reduced stroke incidence in NVAF patients.
- Low-dose warfarin demonstrated comparable efficacy to higher doses with fewer bleeding complications.
- Aspirin also showed a reduction in stroke incidence in one study.
- Overall benefits of long-term low-dose warfarin outweigh bleeding risks for most NVAF patients.
Conclusions:
- Low-dose warfarin is an effective and safe option for stroke prevention in NVAF.
- Aspirin presents a suitable alternative for patients unable to use warfarin or at low stroke risk.
- Evidence supports warfarin and potentially aspirin for managing stroke risk in NVAF.
Related Concept Videos
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.6K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.6K
01:18Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.7K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.7K
01:26Coronary Artery Disease IV: Preventive Measures
890
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
890
01:25Dysrhythmias VI: Management of Dysrhythmias
597
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
597
01:29Venous Thrombosis III: Interprofessional Care
482
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
482
01:30Venous Thrombosis IV: Nursing Management
415
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
415